TITLE

Comparison of the Efficacy of Liquid and Freeze-dried Strains of B.C.G. Vaccine in Preventing Tuberculosis

AUTHOR(S)
Springett, V. H.; Sutherland, Ian
PUB. DATE
October 1970
SOURCE
British Medical Journal;10/18/1970, Vol. 4 Issue 4728, p148
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64321677

 

Related Articles

  • An explanation for BCG's unreliable reputation?  // Bulletin of the World Health Organization;1999, Vol. 77 Issue 8, p704 

    Reports the loss of substantial number of genes in Bacille Calmette-Guerin (BCG), a mycobacterium used to make tuberculosis vaccine. Derivation of vaccine from an isolate of Mycobacterium bovis; Comparison of genomes of BCG strains and M. bovis with M. tuberculosis; Uncertainty of the effect of...

  • WHO statement on BCG revaccination for the prevention of tuberculosis.  // Bulletin of the World Health Organization;1995, Vol. 73 Issue 6, p805 

    Presents the statement of the World Health Organization regarding the use of the bacille Calmette-Guerin (BCG) vaccine for the prevention of tuberculosis. Efficacy of BCG vaccines; Tuberculin skin testing; Efficacy of repeated BCG vaccination; Recommendations.

  • BCG vaccine in Korea. Sun Myung Joung; Sungweon Ryoo // Clinical & Experimental Vaccine Research;Jul2013, Vol. 2 Issue 2, p83 

    The anti-tuberculosis Bacille de Calmette et Guérin (BCG) vaccine was developed between 1905 and 1921 at Pasteur Institutes of Lille in France, and was adopted by many countries. BCG strains comprise natural mutants of major virulence factors of Mycobacterium tuberculosis and that BCG...

  • BCG vaccine:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p37 

    The article presents an encyclopedia entry for BCG vaccine. It refers to a tuberculosis vaccine made from a freeze-dried preparation of live strain of Mycobacterium bovis. The vaccine is regularly used for the vaccination of children only in areas with high incidence rate of tuberculosis in the...

  • A Broad View of Tuberculosis Progress.  // Clinical Pediatrics;Aug1972, Vol. 11 Issue 8, p464 

    Discusses the worldwide progress of tuberculosis treatment and prevention. Epidemiology of tuberculosis; Supervised domiciliary treatment with isoniazid and paraaminosalicylic acid; Immunization; Attempts to improve the efficacy of BCG vaccine.

  • The Type of Growth Medium Affects the Presence of a Mycobacterial Capsule and Is Associated With Differences in Protective Efficacy of BCG Vaccination Against Mycobacterium tuberculosis. Prados-Rosales, Rafael; Carreño, Leandro J.; Weinrick, Brian; Batista-Gonzalez, Ana; Glatman-Freedman, Aarona; Jiayong Xu; Chan, John; Jacobs Jr., William R.; Porcelli, Steven A.; Casadevall, Arturo; Xu, Jiayong; Jacobs, William R Jr // Journal of Infectious Diseases;8/1/2016, Vol. 214 Issue 3, p426 

    Background: Bacillus Calmette-Guerin (BCG) vaccine is widely used for the prevention of tuberculosis, despite limited efficacy. Most immunological studies of BCG or Mycobacterium tuberculosis strains grow bacteria in the presence of detergent, which also strips the mycobacterial...

  • BCG in Britain.  // British Medical Journal;9/27/1980, Vol. 281 Issue 6244, p825 

    Assesses the efficacy of BCG vaccination in treating tuberculosis in Great Britain. Mode of transmission of tuberculosis; Reduction in the incidence of tuberculosis; Complications of BCG vaccination.

  • The Effect of Bacille Calmette-Guérin Vaccine Strain and Route of Administration on Induced Immune Responses in Vaccinated Infants. Davids, Virginia; Hanekom, Willem A.; Mansoor, Nazma; Gamieldien, Hoyam; Gelderbloem, Sebastian J.; Hawkridge, Anthony; Hussey, Gregory D.; Hughes, E. Jane; Soler, Jorge; Murray, Rose Ann; Ress, Stanley R.; Kaplan, Gilla // Journal of Infectious Diseases;2/15/2006, Vol. 193 Issue 4, p531 

    Vaccination with Mycobacterium bovis bacille Calmette-Guérin (BCG) has variable efficacy in preventing tuberculosis. Both BCG strain and route of administration have been implicated in determining efficacy; however, these variables are not considered in current clinical recommendations for...

  • Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection. Zheng Zhong Xu; Xiang Chen; Ting Hu; Chuang Meng; Xiao Bo Wang; Yan Rao; Xiao Ming Zhang; Yue Lan Yin; Zhi Ming Pan; Xin An Jiao // Frontiers in Cellular & Infection Microbiology;1/28/2016, p1 

    Mycobacterium bovis bacillus Calmette-Guérin (BCG) is currently the only vaccine available for preventing tuberculosis (TB), however, BCG has varying success in preventing pulmonary TB. In this study, a recombinant BCG (rBCG::Ag85A) strain overexpressing the immunodominant Ag85A antigen was...

  • Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur. Berrêdo-Pinho, Marcia; Kalume, Dario E.; Correa, Paloma R.; Gomes, Leonardo H. F.; Pereira, Melissa P.; da Silva, Renata F.; Castello-Branco, Luiz R. R.; Degrave, Wim M.; Mendonça-Lima, Leila // BMC Microbiology;2011, Vol. 11 Issue 1, p80 

    Background: Bacille Calmette-Guerin (BCG) is currently the only available vaccine against tuberculosis (TB) and comprises a heterogeneous family of sub-strains with genotypic and phenotypic differences. The World Health Organization (WHO) affirms that the characterization of BCG sub-strains,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics